Pharma News Novel therapy for ESR1-mutated advanced or metastatic breast cancer approved by FDA Read more
Pharma News Pembrolizumab plus chemotherapy delays disease progression in endometrial carcinoma Read more
Pharma News ADDING ABEMACICLIB TO FIRST LINE ENDOCRINE THERAPY RESULTS IN A CLINICALLY RELEVANT SURVIVAL B... Read more
Pharma News FDA approval to tremelimumab plus durvalumab with chemotherapy for NSCLC patients Read more
Pharma News FDA grants Orphan drug designation to KIR-CAR T cell therapy for mesothelioma patients Read more
